Phase I trial of Cadherin-11 inhibitor SDP 051 in volunteers
Phase of Trial: Phase I
Latest Information Update: 23 Jan 2014
At a glance
- Drugs RG 6125 (Primary)
- Indications Fibrosis; Rheumatoid arthritis
- Focus Adverse reactions
- 23 Jan 2014 New trial record
- 08 Jan 2014 Doses up to 10 mg/kg were well tolerated, according to results reported in an Adheron Therapeutics media release.
- 08 Jan 2014 This study is recently completed, according to an Adheron Therapeutics media release.